The association of plasma fibrinogen with clinicopathological features and prognosis in esophageal cancer patients

Fang-Teng Liu; Hui Gao; Chang-Wen Wu; Zheng-Ming Zhu

doi:10.18632/oncotarget.21746

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

The association of plasma fibrinogen with clinicopathological features and prognosis in esophageal cancer patients

Fang-Teng Liu _, Hui Gao, Chang-Wen Wu and Zheng-Ming Zhu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:93029-93038. https://doi.org/10.18632/oncotarget.21746

Metrics: PDF 1238 views | HTML 1940 views | ?

Abstract

Fang-Teng Liu1,*, Hui Gao1,*, Chang-Wen Wu2,* and Zheng-Ming Zhu1

1Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi Province, P.R. China

2Department of Urology, The Second Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi Province, P.R. China

*These authors have contributed equally to this work

Correspondence to:

Zheng-ming Zhu, email: [email protected]

Keywords: plasma fibrinogen, esophageal cancer, prognosis, clinicopathological feature, biomarker

Received: May 07, 2017 Accepted: August 04, 2017 Published: October 10, 2017

ABSTRACT

Background: Numerous studies have shown that plasma fibrinogen was linked to esophageal cancer (EC) risk. However, the clinical significance of plasma fibrinogen in EC patients remain unclear and need to be further clarified.

Results: A total of 2865 patients with EC from 11 published studies were included in this meta-analysis. The prognostic and clinical relevance of plasma fibrinogen were evaluated in EC patients. Statistical significance of the pooled hazard ratio (HR) was found for overall survival (OS), disease free survival (DFS) and recurrence-free survival (RFS) in EC. Subgroup analyses for OS were also performed to confirm the prognostic value of plasma fibrinogen. Additionally, the overall results indicated that elevated plasma fibrinogen was significantly associated with tumor invasion, lymph node metastasis (LNM) and clinical stage.

Materials and Methods: A comprehensive literature retrieval was performed in PubMed, Embase, Cochrane database, Web of science and Chinese National Knowledge Infrastructure (CNKI) and Wanfang databases to identify relevant studies published prior to April 15, 2017.

Conclusions: Elevated plasma fibrinogen could be served as a promising biomarker for predicting a poor prognosis and unfavorable clinicopathologic features for EC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21746

Publication Alerts

Research Papers:

The association of plasma fibrinogen with clinicopathological features and prognosis in esophageal cancer patients

Abstract